# A Study of Anti-HIV Monoclonal Antibody KD-247

> **NCT00917813** · PHASE1 · COMPLETED · sponsor: **The Chemo-Sero-Therapeutic Research Institute** · enrollment: 27 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** KD-247
- **DRUG:** Physiological saline

## Key facts

- **NCT ID:** NCT00917813
- **Lead sponsor:** The Chemo-Sero-Therapeutic Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2012-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917813, "A Study of Anti-HIV Monoclonal Antibody KD-247". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00917813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*